Published in Gut Liver on November 15, 2017
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA (2007) 9.97
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994) 9.60
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet (2006) 9.17
Pancreatic cancer. Lancet (2011) 8.54
Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med (1991) 8.19
Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst (1999) 8.15
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science (2009) 7.39
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet (1998) 7.36
Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst (2002) 6.58
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
The Fanconi anaemia/BRCA pathway. Nat Rev Cancer (2003) 5.89
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg (2004) 5.12
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst (1997) 4.23
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med (1995) 4.10
Familial adenomatous polyposis. Am J Gastroenterol (2006) 3.77
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst (2002) 3.65
Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res (2004) 3.31
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol (2006) 3.24
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20
The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol (1990) 3.20
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet (1994) 3.05
Recent progress in pancreatic cancer. CA Cancer J Clin (2013) 2.88
Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer (2007) 2.85
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res (1976) 2.46
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol (2010) 2.32
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet (2006) 2.17
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut (2012) 2.17
A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg (2006) 2.15
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology (2009) 2.08
Peutz-Jeghers syndrome. J Med Genet (1997) 2.01
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol (2012) 1.99
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol (2014) 1.81
MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA (2014) 1.78
Precursors to pancreatic cancer. Gastroenterol Clin North Am (2007) 1.75
Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med (2006) 1.73
Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer (2011) 1.68
Current trends in pancreatic cystic neoplasms. Arch Surg (2009) 1.68
Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut (2007) 1.68
Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients. Clin Cancer Res (2009) 1.65
Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA (2001) 1.64
Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc (2007) 1.62
Stool screening for colorectal cancer: molecular approaches. Gastroenterology (2005) 1.61
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology (2003) 1.59
Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg (2003) 1.58
Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol (2003) 1.57
Update on familial pancreatic cancer. Adv Surg (2010) 1.54
Investigational biomarkers for pancreatic adenocarcinoma: where do we stand? South Med J (2014) 1.45
Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol (1982) 1.42
Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology (2013) 1.39
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer (2012) 1.39
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive. Cancer J (2012) 1.36
Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol (2002) 1.36
Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology (2008) 1.35
Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol (2010) 1.35
Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas (2007) 1.35
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer (2010) 1.34
The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29
Familial pancreatic cancer--current knowledge. Nat Rev Gastroenterol Hepatol (2012) 1.27
Quantitative proteomic profiling of pancreatic cancer juice. Proteomics (2006) 1.25
Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer (2011) 1.20
Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet (1999) 1.20
Diabetes and pancreatic cancer. Endocr Relat Cancer (2012) 1.20
Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc (2002) 1.17
Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog (2012) 1.17
Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J Gastrointest Surg (2011) 1.15
Genetics of pancreatitis. Curr Opin Gastroenterol (2011) 1.11
Early detection of sporadic pancreatic cancer: summative review. Pancreas (2015) 1.10
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol (2015) 1.09
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer (2011) 1.06
Anticipation in familial pancreatic cancer. Gut (2005) 1.00
Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet (1990) 1.00
History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol (2013) 0.95
Diabetes, pancreatic cancer, and metformin therapy. Front Physiol (2014) 0.92
Absence of deleterious palladin mutations in patients with familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Palladin mutation causes familial pancreatic cancer: absence in European families. PLoS Med (2007) 0.91
Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease. Nat Rev Gastroenterol Hepatol (2012) 0.89
Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed Res Int (2014) 0.88
Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol (2014) 0.88
New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice. Clin Cancer Res (2015) 0.87
MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions. World J Gastrointest Oncol (2016) 0.87
A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut (2015) 0.87
Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model. Cancer Lett (2012) 0.86
Occupational risk factors and pancreatic cancer: a review of recent findings. Mol Carcinog (2012) 0.85
Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet (1994) 0.84